209 related articles for article (PubMed ID: 16172311)
1. Primary cutaneous marginal zone B-cell lymphoma: clinical and therapeutic features in 50 cases.
Hoefnagel JJ; Vermeer MH; Jansen PM; Heule F; van Voorst Vader PC; Sanders CJ; Gerritsen MJ; Geerts ML; Meijer CJ; Noordijk EM; Willemze R
Arch Dermatol; 2005 Sep; 141(9):1139-45. PubMed ID: 16172311
[TBL] [Abstract][Full Text] [Related]
2. Primary cutaneous marginal zone B-cell lymphoma: response to treatment and disease-free survival in a series of 137 patients.
Servitje O; Muniesa C; Benavente Y; Monsálvez V; Garcia-Muret MP; Gallardo F; Domingo-Domenech E; Lucas A; Climent F; Rodriguez-Peralto JL; Ortiz-Romero PL; Sandoval J; Pujol RM; Estrach MT
J Am Acad Dermatol; 2013 Sep; 69(3):357-65. PubMed ID: 23796549
[TBL] [Abstract][Full Text] [Related]
3. Primary cutaneous marginal zone B-cell lymphoma in a patient with chronic lymphocytic leukaemia.
Robak E; Jesionek-Kupnicka D; Robak T; Holub A; Wawrzyniak E; Bartkowiak J; Bednarek A; Constantinu M; Urbanska-Rys H
Br J Dermatol; 2007 Sep; 157(3):591-5. PubMed ID: 17697078
[TBL] [Abstract][Full Text] [Related]
4. Applying the new TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome in primary cutaneous marginal zone lymphoma.
Gerami P; Wickless SC; Rosen S; Kuzel TM; Ciurea A; Havey J; Guitart J
J Am Acad Dermatol; 2008 Aug; 59(2):245-54. PubMed ID: 18486274
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous involvement with marginal zone lymphoma.
Gerami P; Wickless SC; Querfeld C; Rosen ST; Kuzel TM; Guitart J
J Am Acad Dermatol; 2010 Jul; 63(1):142-5. PubMed ID: 20462658
[TBL] [Abstract][Full Text] [Related]
6. Results of radiotherapy in 153 primary cutaneous B-Cell lymphomas classified according to the WHO-EORTC classification.
Senff NJ; Hoefnagel JJ; Neelis KJ; Vermeer MH; Noordijk EM; Willemze R;
Arch Dermatol; 2007 Dec; 143(12):1520-6. PubMed ID: 18087001
[TBL] [Abstract][Full Text] [Related]
7. Cutaneous B-cell lymphoma: pathological spectrum and clinical outcome in 51 consecutive patients.
Sah A; Barrans SL; Parapia LA; Jack AS; Owen RG
Am J Hematol; 2004 Apr; 75(4):195-9. PubMed ID: 15054808
[TBL] [Abstract][Full Text] [Related]
8. Primary cutaneous marginal zone B-cell lymphoma.
Tsuji K; Suzuki D; Naito Y; Sato Y; Yoshino T; Iwatsuki K
Eur J Dermatol; 2005; 15(6):480-3. PubMed ID: 16280304
[TBL] [Abstract][Full Text] [Related]
9. Low-dose palliative radiotherapy for cutaneous B- and T-cell lymphomas.
Neelis KJ; Schimmel EC; Vermeer MH; Senff NJ; Willemze R; Noordijk EM
Int J Radiat Oncol Biol Phys; 2009 May; 74(1):154-8. PubMed ID: 18834672
[TBL] [Abstract][Full Text] [Related]
10. Symmetrical primary cutaneous marginal zone lymphoma associated with rheumatoid arthritis.
Yildirim FE; Karaduman A; Hürmüz P; Ozyar E; Barişta I; Sağlam A
J Cutan Pathol; 2010 May; 37(5):600-4. PubMed ID: 19674036
[TBL] [Abstract][Full Text] [Related]
11. Anetodermic primary cutaneous B-cell lymphoma: a unique clinicopathological presentation of lymphoma possibly associated with antiphospholipid antibodies.
Hodak E; Feuerman H; Barzilai A; David M; Cerroni L; Feinmesser M
Arch Dermatol; 2010 Feb; 146(2):175-82. PubMed ID: 20157029
[TBL] [Abstract][Full Text] [Related]
12. Intralesional and intravenous treatment of cutaneous B-cell lymphomas with the monoclonal anti-CD20 antibody rituximab: report and follow-up of eight cases.
Kerl K; Prins C; Saurat JH; French LE
Br J Dermatol; 2006 Dec; 155(6):1197-200. PubMed ID: 17107389
[TBL] [Abstract][Full Text] [Related]
13. Favorable outcome of primary cutaneous marginal zone lymphoma treated with intralesional rituximab.
Kyrtsonis MC; Siakantaris MP; Kalpadakis C; Dimopoulou MN; Vassilakopoulos TP; Kontopidou FN; Antoniou C; Korkolopoulou P; Panayiotidis P; Pangalis GA
Eur J Haematol; 2006 Oct; 77(4):300-3. PubMed ID: 16856917
[TBL] [Abstract][Full Text] [Related]
14. Primary cutaneous diffuse large B-cell lymphoma, leg type: clinicopathologic features and prognostic analysis in 60 cases.
Grange F; Beylot-Barry M; Courville P; Maubec E; Bagot M; Vergier B; Souteyrand P; Machet L; Dalac S; Esteve E; Templier I; Delaporte E; Avril MF; Robert C; Dalle S; Laroche L; Delaunay M; Joly P; Wechsler J; Petrella T
Arch Dermatol; 2007 Sep; 143(9):1144-50. PubMed ID: 17875875
[TBL] [Abstract][Full Text] [Related]
15. Primary cutaneous B-cell lymphoma treated with radiotherapy: a comparison of the European Organization for Research and Treatment of Cancer and the WHO classification systems.
Smith BD; Glusac EJ; McNiff JM; Smith GL; Heald PW; Cooper DL; Wilson LD
J Clin Oncol; 2004 Feb; 22(4):634-9. PubMed ID: 14966086
[TBL] [Abstract][Full Text] [Related]
16. Orbital marginal zone B-cell lymphoma of MALT: radiotherapy results and clinical behavior.
Suh CO; Shim SJ; Lee SW; Yang WI; Lee SY; Hahn JS
Int J Radiat Oncol Biol Phys; 2006 May; 65(1):228-33. PubMed ID: 16503386
[TBL] [Abstract][Full Text] [Related]
17. Primary cutaneous lymphoma: local control and survival in patients treated with radiotherapy.
De Sanctis V; Osti MF; Berardi F; Ardito F; Valeriani M; Martelli M; Enrici RM
Anticancer Res; 2007; 27(1B):601-5. PubMed ID: 17348448
[TBL] [Abstract][Full Text] [Related]
18. Primary cutaneous marginal zone B-cell lymphoma: clinical and histological aspects.
Khaled A; Sassi S; Fazaa B; Ben Hassouna J; Ben Romdhane K; Kamoun MR
Pathologica; 2009 Feb; 101(1):18-20. PubMed ID: 19771768
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of pegylated liposomal doxorubicin in primary cutaneous B-cell lymphomas and comparison with the commonly used therapies.
Pulini S; Rupoli S; Goteri G; Pimpinelli N; Alterini R; Bettacchi A; Mulattieri S; Picardi P; Tassetti A; Scortechini AR; Fioritoni G; Leoni P
Eur J Haematol; 2009 Mar; 82(3):184-93. PubMed ID: 19215609
[TBL] [Abstract][Full Text] [Related]
20. Primary cutaneous small/medium CD4+ T-cell lymphomas: a heterogeneous group of tumors with different clinicopathologic features and outcome.
Garcia-Herrera A; Colomo L; Camós M; Carreras J; Balague O; Martinez A; Lopéz-Guillermo A; Estrach T; Campo E
J Clin Oncol; 2008 Jul; 26(20):3364-71. PubMed ID: 18541895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
